Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company focused on developing Alpha DaRT, a targeted alpha-radiation platform designed for the treatment of solid tumors. The company’s core work centers on research, clinical development, and commercialization of localized cancer therapies that deliver alpha particles directly inside tumor tissue while limiting exposure to surrounding healthy tissue. Alpha Tau Medical Ltd. is active in a range of oncology indications, including skin, oral, pancreatic, prostate, lung, liver, breast, and brain cancers, reflecting the broad potential use of its technology across difficult-to-treat solid tumors. Headquartered in Jerusalem, Israel, the company operates as a medical technology business serving the oncology sector and is centered on advancing precision radiation approaches for cancer care.

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Uzi Sofer

Employees

121

Headquarters

Jerusalem, Israel

Website

www.alphatau.com